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In each heart taken from autopsies of 14 men with idio-
pathic hemochromatosis, the conduction system, atria
and 10 sites in the ventricles were histologically graded
for stainable iron. Stainable iron was exclusively sar-
coplasmic; none was observed in the interstitium. The
histologicgrade for the same anatomic site varied among
hearts and among different anatomic sites in the same
heart. Ten hearts had stainable iron in all ventricular
sites; one of the three hearts from patients who had
undergone therapeutic phlebotomy had no iron at any
site. Seven hearts had iron in the atria but at a lesser
grade than that found in the ventricles; six hearts had
mild focal iron deposition in the atrioventricular con-
duction system. None of the 14 hearts had stainable iron
in the sinus node.
Elemental iron was quantitated by atomic absorption
spectroscopy in ventricular specimenscontiguous to those
Idiopathic hemochromatosis is an autosomal recessive dis-
order, characterized by parenchymal iron loading of inde-
terminate cause, that may lead to multiple organ failure in
untreated patients (I). HLA genotyping studies (2) and au-
topsy studies (3,4) suggest that this disorder is more com-
mon than previously recognized. Its incidence, once be-
lieved to be 1/10,000, has recently been estimated to be
2 to 3/1 ,000, and 10% of the population may be heterozy-
gous (2).
Cardiac failure is the leading cause of death in idiopathic
hemochromatosis ( I). However, the cardiac histopathologic
abnormalities in this disease have not been well described.
Previous reports (5-8) on the cardiac histopathology of iron
overload disorders have been confined almost exclusively
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studied histologically and also in age-matched control
hearts. Elemental iron content was markedly increased
in hearts with idiopathic hemochromatosiscompared with
control hearts (p < 0.01). The quantity of elemental iron
varied greatly, similar to stainable iron, but was highest
subepicardially. Among the hearts from the 11 patients
without prior phlebotomy, three had no stainable iron
in the right ventricular septal subendocardium, sug-
gesting that sampling error may be a problem in the
evaluation of hemochromatosis by endomyocardial bi-
opsy.
The sarcoplasmic location of the iron indicates that
cardiac involvement in idiopathic hemochromatosis rep-
resents a storage disease and not an infiltrative process;
this finding is consistent with the normal ventricular wall
thicknesses observed.
(J Am Coil CardioI1987;lO:1239-43)
to patients with acquired hemochromatosis. The purpose of
this study was to describe the microscopic features and to
analyze elemental iron in the heart from autopsy of patients
with idiopathic hemochromatosis.
Methods
Study cases. Fourteen hearts from the tissue registry at
our institution were studied. These were from patients with
idiopathic hemochromatosis who died between 1947 and
1983; diagnosis was antemortem in seven and postmortem
in seven. The criteria for inclusion in the study were post-
mortem demonstration of hepatic iron deposition and as-
sociated cirrhosis without a history of anemia and transfu-
sion or known excessive oral ingestion of iron. For each
patient with idiopathic hemochromatosis, the clinical history
was reviewed and the age, sex and cause of death were
recorded.
The 14 hearts were weighed, and their wall thicknesses
were measured. Each heart was also evaluated grossly for
the presence of valvular and ischemic heart disease. Only
grade 4 coronary atherosclerosis (>75% obstruction of a
0735-1097/87/$3.50
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cross-sectional area) was considered a critical lesion. In
addition, 14 hearts without evidence of disease, matched
with the idiopathic hemochromatosis hearts for age of pa-
tients at death and duration of formalin preservation, were
obtained as controls for iron analyses.
Histology. Histologic estimations of stainable iron and
fibrosis in the 14 study hearts were made by two of the
investigators without knowledge of the results of the iron
analyses. The extents of both stainable iron and fibrosis
were graded by using an arbitrary 5 point scale (0 = 0%;
I = I to 25%; 2 = 26 to 50%; 3 = 51 to 75%; 4 =
>75%) based on the number of myocytes containing stain-
able iron or of myocardium involved by fibrosis. The an-
atomic sites studied included the right ventricular free wall;
the right and left ventricular septal subendocardium; a core
specimen from the septum; specimens from the subendo-
cardial, midmyocardial and subepicardial layers of the left
ventricular anterior and inferior walls at the level of the
mitral papillary muscles; the atria; the sinus node and the
atrioventricular conduction system.
Analysis of ventricular elemental iron. Dried ventric-
ular specimens contiguous to those studied histologically
(total of 140 specimens) were analyzed for elemental iron
by flameless atomic absorption spectroscopy (Perkin-Elmer
model 500). Specimens from each of the 10 ventricular sites
in the 14 control hearts also were studied. Quality control
studies, using National Bureau of Standards reference ma-
terial, showed agreement within 1%.
Statistical analysis. For the elemental iron determina-
tions, matched pair analysis was performed to test for the
significance of differences between idiopathic hemochro-
matosis and control hearts by anatomic site-paired t test
for continuous variables and signed-rank test for ordinal
variables. Repeated measures of analysis of variance for
continuous variables and Friedman's procedure for ordinal
variables were used to determine whether differences in
levels of myocardial iron by anatomic site in individual
hearts reached statistical significance. Student-Neuman-
Keuls inultiple comparison procedures were used to deter-
mine which sites were different from one another. Spear-
man's rank correlation coefficient was used to estimate the
degree of association between methods of estimation of
elemental iron; p < 0.05 was regarded as evidence of sta-
tistical significance.
Results
Age and sex distribution and cause of death. All of
the 14 patients and 14 control subjects were men. Age ranges
were 43 to 74 years for idiopathic hemochromatosis and 44
to 75 years for controls (mean age for each group = 59
years). Causes of death in the idiopathic hemochromatosis
group were liver failure in seven patients. hepatocellular
carcinoma in three, sudden death in two, sepsis in one and
acute aortic dissection in one.
Gross pathology. Heart weight ranged from 275 to 610
g (mean 425). Wall thickness ranged from 1.0 to 1.6 ern
(mean 1.3) for the left ventricular free wall, 1.2 to 1.7 em
(mean 1.4) for the ventricular septum and 0.20 to 0.50 em
(mean 0.35) for the right ventricular free wall.
Additional findings included combined valvular disease
and grade 4 coronary artery disease in three patients, val-
vular disease alone in two patients and coronary artery dis-
ease alone in one patient. In only one patient with severe
aortic stenosis, however, was severity of the valvular heart
disease more than mild.
Histopathology. Ventricular myocardium. Stainable iron
was exclusively sarcoplasmic; no iron was observed in the
interstitium. The pattern of distribution of stainable iron was
Figure 1. Stainable iron in the left ventricularmyocardium of two
patients. Top, Severe iron deposition. Bottom, Mild iron depo-
sition. (Iron stain; Top, x 360, reduced by 15%;Bottom, x 180,
reduced by 15%.)
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Figure 3. Stainable iron in the atrioventricular node. (Iron stain;
Top, x90, reduced by 15%; Bottom, x 360, reduced by 15%.)
f ,
either focal or diffuse, and the extent varied from none to
severe (Fig. I). Variations in extent were observed among
different hearts and within individual hearts by anatomic
site. In general, variations among hearts were greater than
variations within a single heart.
In 10 (71%) ofthe 14 hearts, stainable iron was present
in all ventricular sites. In one of the three hearts from
patients who had undergone phlebotomy before death, there
was no stainable iron at any site. Among the II hearts from
patients without prior phlebotomy, three (27%) had no stain-
able iron in subendocardial specimens from the septal aspect
of the right ventricle, corresponding to sites commonly used
for endomyocardial biopsy in living patients (Fig. 2). In
two of these three hearts, there was stainable iron at other
anatomic sites. The third heart was from a patient who had
had esophageal varices and a history of chronic low grade
gastrointestinalbleeding that had not been treated with trans-
fusions.
Fibrosis was either absent or mild (grade I) at all ven-
tricular sites from all patients.
Atrial myocardium. As in the ventricular myocardium,
stainable iron was exclusively sarcoplasmic. In seven hearts
(50%), stainable iron was present in atrial myocardium but
the grade was less than that in the ventricles.
Conduction system. No heart had stainable iron in the
sinus node. Six (43%) had stainable iron in the AV con-
duction system. In four of these six, stainable iron was
observed in the AV node (Fig. 3) and in two hearts it was
confined either to the perinodal tissues or to the bundle
branches. These six hearts included the five hearts with the
highest levels of ventricular elemental iron as determined
by atomic absorption spectroscopy.
[ron quantitation. For all sites in the entire group with
idiopathic hemochromatosis, elemental iron (Fig. 4) ranged
from 433 to 7,474 jLg/g dry weight (mean 1,701). Mean
7,500.--------~.-----------,
Figure 2. Concentration of myocardial elemental iron (based on
tissue dry weight) by histologic grade of stainable iron in the right
ventricular septal subendocardium for 14 hearts from patients with
idiopathic hemochromatosis. See text for grading. The black cir-
cles with numbers correspond to values for Patients I to 14.
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elemental iron for individual hearts ranged from 647 to
5,095 jLg/g.
For all anatomic sites in the entire control group, ele-
mental iron ranged from 136to 817 jLg/g (mean 399). Mean
elemental iron in individual control hearts ranged from 183
to 674 jLg/g.
For each anatomic site there was marked variation in
the quantity of iron found in different study hearts. How-
ever, there was less variation among different anatomic sites
in individual hearts. The iron levels in control hearts were
lower and the range was relatively narrow.
/11 3 oj" the /4 study hearts, elemental iron values for all
anatomic sites consistently fell within the range of normal.
One of these three hearts came from a patient with a history
of therapeutic phlebotomy before death and one came from
a patient with a history of chronic low grade gastrointestinal
blood loss that had not been treated with transfusions.
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Figure 4. Concentration of myocardial elemental iron (based on
tissue dry weight) determined by atomic absorption spectroscopy
in hearts from idiopathic hemochromatosis patients (n = 14) and
from control hearts (n = 14), displayed by anatomic site. The
black circles correspond to iron values for hearts from the 14
idiopathic hemochromatosis patients. All values foreach idiopathic
hemochromatosis patient are displayed. For control patients, the
range of iron values is represented for each anatomic site by a
vertical hatched bar. Horizontal lines represent mean iron levels
for each anatomic site for study and control hearts. LV ANT =
left ventricular anterior wall; LV INF = left ventricular inferior
wall; Mid = midmyocardial region; RV = right ventricle;
Subendo = subendocardial region; Subepi = subepicardial re-
gion.
Of the 10 ventricular anatomic sites analyzed for ele-
mental iron, the subepicardial layers had the highest levels
within the study group, although there was marked indi-
vidual variation. The difference between subepicardial and
subendocardial sites was statistically significant (p < 0.01,
Student-Neuman-Keuls multiple comparison procedure). No
significant differences among anatomic sites were observed
within the control group.
In no matched-pair analysis did the quantity of elemental
iron in a control heart exceed that in a study heart at the
Figure 5. Concentration (based on tissue dry weight) of myo-
cardial elemental iron displayed by histologic grade of stainable
iron for all 10 anatomic sites for each of the 14 study hearts.
Horizontal lines represent median values of elemental iron.
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same anatomic site. Overall, elemental iron at each of the
anatomic sites was significantly higher in the hearts from
patients with idiopathic hemochromatosis than in the control
hearts (p < 0.01).
Although there appeared to be a correlation between
quantitative histologic grade and median quantitative ele-
mental iron value, the ranges of quantitative values over-
lapped considerably (Fig. 5).
Discussion
Previous studies. The association between histologi-
cally demonstrable myocardial iron and cardiac dysfunction
in patients with iron overload disorders has been described
(5-11). However, reports on the cardiac histopathology of
iron overload disorders (5-8) have been confined almost
exclusively to patients with acquired hemochromatosis as-
sociated with chronic transfusions for refractory anemias.
In contrast, the histopathologic characteristics of the heart
in idiopathic hemochromatosis have not been well charac-
terized. It is unknown whether the myocardial iron distri-
bution associated with idiopathic hemochromatosis differs
from that associated with acquired hemochromatosis.
Schellhammeret a!. (5) studied six hearts from autopsies
of patients with acquired hemochromatosis and found stain-
able iron in all parts of the conduction system, including
the sinus node. Vigorita and Hutchins (6) also studied car-
diac histopathology in six patients with acquired hemo-
chromatosis and reported variable grades of iron staining in
different patients and among different anatomic sites. The
sinus node was involved in two cases, and the AV con-
duction system was involved in five. Stainable iron was
observed in the ventricular myocardium of all patients.
James (7) described cardiac histopathologic findings in
two patients with acquired hemochromatosis and in three
with idiopathic hemochromatosis. In each, the AV node
contained stainable iron but the sinus node was spared. All
hearts had diffuse stainable myocardial iron, and no differ-
ences were described between hearts from patients with
idiopathic hemochromatosis and hearts from patients with
acquired hemochromatosis.
The most comprehensive reported study of cardiac in-
volvement in iron overload disorders, by Buja and Roberts
(8), included cardiac histopathologic findings in 135 pa-
tients. However, only 19 of them had stainable iron in the
myocardium; 3 of the 19 had idiopathic hemochromatosis.
These authors observed that stainable iron in the cardiac
conduction tissue was minimal and was less than that in
atrial or ventricular myocardium. In their study, iron de-
posits always appeared to be greatest in the subepicardial
third, intermediate in the subendocardial third and least in
the middle third of the myocardium. Histopathologic dif-
ferences between patients with idiopathic hemochromatosis
JACC Vol. 10, No.6
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and those with other iron overload disorders were not de-
scribed. However, two of the three patients with idiopathic
hemochromatosis in their series also had received chronic
transfusions for refractory anemia (one patient had leukemia
and the other had hemolytic anemia). Therefore, in only
one case was stainable cardiac iron attributable to idiopathic
hemochromatosis alone.
Present study. In our study, the severity of cardiac iron
deposition varied considerably, not only among hearts but
also among anatomic sites in individual hearts. As in the
report by James (7), the sinus node was spared in all of our
14 cases; the AV conduction system was involved in 6 of
them. In contrast to previous studies, regional anatomic
differences in ventricular myocardial iron were demon-
strated by quantitative elemental analysis and by semiquan-
titative histologic grading of stainable iron. The subepicar-
dium tended to contain more iron than the midmyocardial
or subendocardial regions, as has been reported for patients
with acquired hemochromatosis (8). Our observations re-
garding the variability in quantity of myocardial iron in
idiopathic hemochromatosis are consistent with the variable
clinical spectrum of cardiac dysfunction, ranging from
asymptomatic patients with normal cardiac function to se-
verely symptomatic patients with end-stage cardiac failure
(12-14).
The subcellular distribution ofstainable cardiac iron was
not described in the previous studies cited. Furthermore,
cardiac hemochromatosis frequently has been described as
an infiltrative process, implying that iron is deposited in the
interstitium. However, we observed no instances of inter-
stitial stainable iron; iron deposition was confined exclu-
sively to the sarcoplasm. Hence, cardiac involvement in
idiopathic hemochromatosis should be regarded as a storage
disease and not as an infiltrative process.
Clinical implications. In the evaluation of patients with
cardiac disease of indeterminate cause, including dilated
(15,16), restrictive (9) and apparent constrictive dysfunction
(17), the diagnosis of idiopathic hemochromatosis should
be considered. In patients who have clinical and biochemical
evidence of iron overload, verification of myocardial in-
volvement may be attempted by endomyocardial biopsy.
Because stainable cardiac iron may be focal and may vary
markedly by anatomic site in idiopathic hemochromatosis,
multiple biopsy specimens should be obtained to minimize
the possibility of sampling error in this potentially reversible
form of cardiac disease.
We express our appreciation to Robert L. Frye, MD for his suggestions
and review of the manuscript.
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